The COVID-19 pandemic has had a devastating global impact, with older adults being most
at risk of death from the disease. However, acute sarcopenia occurs in survivors of COVID …

In this review, we discuss the pathophysiologic and management aspects of acute
sarcopenia in relation to SARS-CoV-2 infection. COVID-19 is as a multi-organ infectious …

The role of skeletal muscle mass in modulating immune response and supporting metabolic
stress has been increasingly confirmed. Patients with sarcopenia, characterized by reduced …

The COVID-19 pandemic is an extraordinary global emergency that has led to the
implementation of unprecedented measures in order to stem the spread of the infection …

Background It has been speculated that patients with sarcopenia are aggravated by the
current novel coronavirus disease 2019 (COVID-19) epidemic. However, there is substantial …

Background Sarcopenia has been associated with patients' poor quality of life, disability,
and hospitalization. As of today, evidence that highlights the association between …

Background Severe clinical pictures and sequelae of COVID‐19 disease are immune
mediated and characterized by a 'cytokine storm'. Skeletal muscle has emerged as a potent …

The relationship between skeletal muscle mass at the beginning of the post-acute
rehabilitation phase and rehabilitation outcomes has been scarcely investigated. The aim of …

Background: The post-COVID-19 condition, defined as COVID-19-related signs and
symptoms lasting at least 2 months and persisting more than 3 months after infection …

Although the numbers of aged populations have risen considerably in the last few decades,
the current coronavirus disease 2019 (COVID‐19) has revealed an extensive vulnerability …